Home › Funds › Caligan Partners LP › VRCA

Caligan Partners LP position in VRCA

VERRICA PHARMACEUTICALS INC · Health Care

Caligan Partners LP reported holding 923,910 shares of VRCA (VERRICA PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$5.7M, representing 0.33% of its reported portfolio and ranking #23 among its reported holdings. Caligan Partners LP has disclosed VRCA holdings in 8 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)923.91K sh
Reported value held$5.65M
Portfolio Weight0.33%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Caligan Partners LP's VRCA position evolved

Caligan Partners LP first disclosed a stake in VRCA in Q3 2023 at 259,593 shares (US$1.0M). The position peaked in Q4 2025 at 923,910 shares, worth US$7.7M. Across 8 filings, Caligan Partners LP increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 923,910 shares valued at US$5.7M. Notable position changes include a 90% trim in Q3 2025 (shares rose 93% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 259.59K $1.01M New
Q4 2024 7.43M $5.20M New
Q1 2025 8.99M $3.98M Add
Q2 2025 9.24M $4.90M Add
Q3 2025 923.91K $3.98M Reduce
Q4 2025 923.91K $7.68M Hold
Q1 2026 923.91K $4.89M Hold
Q2 2026 923.91K $5.65M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VRCA and 13F data

VRCA (VERRICA PHARMACEUTICALS INC) is a Health Care company. 20 other funds we track also report a position in VRCA — the largest reported positions include CANNELL CAPITAL LLC (US$4.8M), Velan Capital Investment Management LP (US$2.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VRCA

All VRCA fund holders →

FAQ

How long has Caligan Partners LP held VRCA?

Caligan Partners LP has disclosed VRCA holdings in 8 of the last 12 reported quarters, going back to Q3 2023.

What is Caligan Partners LP's current position in VRCA?

As of Q2 2026, Caligan Partners LP holds 923.91K shares of VRCA (VERRICA PHARMACEUTICALS INC), valued at $5.65M, representing 0.33% of its reported portfolio and ranking #23.

Has Caligan Partners LP been buying or selling VRCA?

In the latest 13F filing (Q2 2026), Caligan Partners LP held unchanged its position in VRCA. The position peaked in Q4 2025 at 923.91K shares.

Which other funds hold VRCA?

Other major institutional holders of VRCA include CANNELL CAPITAL LLC, Velan Capital Investment Management LP, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.